Improving immunotherapy for advanced prostate cancer
advanced prostate cancer :: Article Creator New Prostate Cancer Treatment Brings Hope To Many This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data. FDA Approves J&J Combo Drug For Prostate Cancers With Certain Genetic Signature Advanced prostate cancer has a new treatment option, a Johnson & Johnson drug that combines two of the company's therapies in a single pill. The FDA approval of the J&J drug, brand name Akeega, covers adults whose cancer has spread and no longer responds to hormone therapies. Crucially, the cancer must also have a BRCA mutation. One of the components of the drug, niraparib, is specifically designed to address this mutation. The FDA also approved a Foundation Medicine companion di...